Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2026-02-22 @ 11:59 PM
Study NCT ID:
NCT00544232
Status:
COMPLETED
Last Update Posted:
2016-02-15
First Post:
2007-10-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)
Sponsor:
GBG Forschungs GmbH
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GBG 49
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None